hVIVO plc (AIM:HVO)
London
· Delayed Price · Currency is GBP · Price in GBX 7.50
+0.30 (4.17%)
Apr 29, 2026, 4:37 PM GMT
hVIVO Revenue
In the year 2025, hVIVO had annual revenue of 49.66M GBP, down -25.00%. hVIVO had revenue of 24.22M in the half year ending December 31, 2025, a decrease of -19.33%.
Revenue
49.66M
Revenue Growth
-25.00%
P/S Ratio
1.00
Revenue / Employee
132.07K
Employees
376
Market Cap
49.47M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ondine Biomedical | 1.18M |
| 4basebio | 1.78M |
| Faron Pharmaceuticals Oy | 1.14M |
| Bioventix | 12.54M |
| ImmuPharma | -69.96K |
| SkinBioTherapeutics | 4.64M |
| Arecor Therapeutics | 1.71M |
| Scancell Holdings | 4.71M |
hVIVO News
- 11 days ago - Full Year 2025 hVIVO PLC Earnings Presentation Transcript - GuruFocus
- 14 days ago - hVIVO Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - hVIVO Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Full Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 7 months ago - Half Year 2025 hVIVO PLC Earnings Presentation Transcript - GuruFocus
- 7 months ago - hVIVO Earnings Call Transcript: H1 2025 - Transcripts
- 10 months ago - hVIVO Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - hVIVO Earnings Call Transcript: H2 2024 - Transcripts